EPOPROSTENOL vs ERENUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
EPOPROSTENOL vs ERENUMAB: Safety Overview
| Metric | EPOPROSTENOL | ERENUMAB |
|---|---|---|
| Total FAERS Reports | 13,322 | 1,183 |
| Deaths Reported | 2,713 | 363 |
| Death Rate | 20.4% | 30.7% |
| Hospitalizations | 8,838 | 498 |
| Average Patient Age | 49.9 yrs | 45.6 yrs |
| % Female Patients | 78.1% | 93.4% |
| FDA Approval Date | Apr 23, 2008 | N/A |
| Manufacturer | Mylan Institutional LLC | Amgen Inc |
| Route | INTRAVENOUS | SUBCUTANEOUS |
| Marketing Status | Discontinued | N/A |